文献速递中医妇科中药与中成药合理使用

中药治疗子宫内膜异位症相关疼痛的疗效与安全性

Efficacy and Safety of Chinese Herbal Medicine for Endometriosis Associated Pain.
PubMed 文献 · Am J Chin Med · 2022-04-26

一项回顾性研究纳入338例经超声或手术确诊的子宫内膜异位症女性,接受中药汤剂每日两次治疗至少3个月至多24个月。结果显示中药可显著降低中重度疼痛评分、改善月经症状频率与严重度,并降低焦虑评分,仅见轻微副作用。

要点

  • 中药汤剂可显著改善子宫内膜异位症相关疼痛及月经症状。
  • 中重度疼痛患者疼痛评分从第3个月至第12个月显著下降。
  • 治疗期间无严重不良事件,仅见轻微副作用。

核心结论

  • 中药可缓解子宫内膜异位症相关疼痛及相关症状,且副作用轻微。

研究设计与样本

  • 回顾性研究,纳入338例经超声或手术确诊的子宫内膜异位症女性,接受中药汤剂每日两次治疗至少3个月至多24个月。

主要发现

  • 中重度疼痛患者疼痛数字评分从第3个月至第12个月显著下降。
  • 任何疼痛水平患者的月经症状频率和严重度评分均显著下降。
  • 焦虑自评量表评分在治疗3、6、12和24个月时显著降低。
  • 抑郁自评量表评分在治疗6个月时显著降低。
  • 无严重不良事件,仅见轻微副作用。

临床怎么用

  • 可考虑使用中药汤剂治疗子宫内膜异位症相关疼痛,疗程至少3个月并关注疼痛与月经症状变化。

局限性

  • 为回顾性研究,作者建议设计大规模随机安慰剂对照试验证实疗效与安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Endometriosis is a chronic, estrogen-dependent condition that causes dysmenorrhea and pelvic pain. Chinese herbal medicine (CHM) has been used for endometriosis for many years in Asian populations. This is a retrospective study in a territory teaching hospital of the China Academy of Chinese Medical Sciences in Beijing, China to compare the short- and long-term effectiveness and safety of CHM for endometriosis associated pain (EAP) before and after CHM treatment. A total of 338 out of 1143 women confirmed with endometriosis by ultrasonogram or surgery within three months received a CHM decoction twice a day for at least 3 and up to 24 months. All data were collected by a Structured Medical Records of Endometriosis (SMRE) in every clinic visit covering the whole treatment period. Pain score, evaluated by Numeric Rating Scale, was significantly decreased from 3rd to 12th month in women with moderate or severe pain. Frequency and severity rating of menstrual symptoms, evaluated by Cox Menstrual Symptom Scale, were significantly decreased in women with any pain level. Psychological changes rated by Self-rating Anxiety Scale (SAS) were significantly lower in 3, 6, 12, and 24 months of treatment, but those by Self-rating Depression Scale (SDS) was significantly decreased in six months of treatment. There was no severe adverse event but only minor side-effects. In conclusion, our study showed that CHM relieved EAP and related symptoms with minimal side-effects after treatment. A large-scale randomized and placebo-controlled trial could be designed to confirm the efficacy and safety.

来源:Am J Chin Med,查看原文。版权归原作者所有。

引用

  1. Lin Y, Hou R, Zhang T, et al. Efficacy and Safety of Chinese Herbal Medicine for Endometriosis Associated Pain. Am J Chin Med. 2022. PMID: 35475975. doi:10.1142/S0192415X22500446

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。